Healthspan and lifespan are measured differently, and the gap between them is the point

Two quantities that are constantly conflated

Lifespan is a single unambiguous number, the interval between birth and death, and recording it requires no judgement call from anyone. Healthspan is a constructed quantity meant to capture the portion of that interval spent without serious disease or functional limitation, and every word in that definition is a decision. Because the boundary of serious has to be drawn somewhere, two research groups can study the same population and report meaningfully different healthspans.

The distinction matters because an intervention does not necessarily move both quantities in the same direction or by the same amount. A treatment that extends survival while leaving disability untouched lengthens lifespan and, on most definitions, shortens the healthy fraction of it.

How healthspan actually gets operationalised

Most working definitions build healthspan from a list of conditions whose first diagnosis ends the healthy period, which makes the measure hostage to diagnostic practice. When screening becomes more sensitive, conditions are recorded earlier in life and measured healthspan falls, even though nothing about the underlying biology has changed. Other definitions use function rather than diagnosis, asking whether a person can climb stairs, dress unaided or walk a set distance without assistance.

Functional definitions are less sensitive to shifts in medical practice, but they rely on self-report or on tests administered in a clinic, and both drift over time. Neither approach is wrong, and the practical consequence is that healthspan figures drawn from different sources are rarely directly comparable.

Why the gap tends to widen

Medicine has become considerably better at preventing death from conditions it cannot cure, which converts what were once fatal events into long-term management. That shift is a genuine achievement, and it also means more of a population lives for years with a diagnosis rather than dying of it. The arithmetic consequence is a widening interval between the end of the healthy period and the end of life, discussed as the compression or expansion of morbidity.

Which of those is happening remains genuinely contested, because the answer depends entirely on which definition of healthspan the analysis has adopted. Anyone presenting that question as settled is describing one definition rather than describing the underlying biology of ageing.

What an intervention can be shown to move

Animal work in this field usually reports survival curves, because death is easy to observe and functional decline in a mouse is not. Where function is measured it tends to be through grip strength, cage activity or maze performance, and those proxies map imperfectly onto human capability. So an intervention described as extending healthspan in animals has usually been shown to extend life while preserving one narrow measured capacity.

That is a real finding, and it is a substantially weaker claim than the one that eventually reaches a consumer audience. Carrying it further requires human trials with functional endpoints, which are slow, expensive and comparatively rare in this literature.

Reading a longevity claim carefully

The first useful question about any longevity claim is which of the two quantities it refers to, since the answer is frequently left implicit. The second is whether the healthspan figure came from diagnosis codes, from functional testing, or from a proxy measured in a laboratory animal. A claim that survives both questions deserves attention, and one that dissolves under them was never a statement about human ageing to begin with.

None of this is grounds for dismissing the field, which has produced serious mechanistic work over several decades of patient effort. It is grounds for treating the two words as separate measurements rather than as interchangeable ways of saying the same agreeable thing.